Hypertension and COVID-19: Potential use of beta-blockers and a call for Randomized Evidence
Hypertension is one of the most common morbidities in COVID-19. Previous studies demonstrated that hypertension increases composite poor outcomes in patients with COVID-19. Beta-blockers is widely used as one of the most common antihypertensive agents. Beta-blockers may hold potential benefits in CO...
Saved in:
Main Authors: | Mochamad Yusuf Alsagaff, -, Eka Prasetya Budi Mulia, - |
---|---|
Format: | Article PeerReviewed |
Language: | English English English English |
Published: |
Cardiological Society of India
2021
|
Subjects: | |
Online Access: | https://repository.unair.ac.id/125540/1/1.%20Hypertension%20and%20COVID-19%20Potential%20use%20of%20beta-blockers%20and%20a%20call%20for%20evidenc_IHJ%202021.pdf https://repository.unair.ac.id/125540/2/karil%201.pdf https://repository.unair.ac.id/125540/3/1.%20Korespondensi.pdf https://repository.unair.ac.id/125540/4/1.%20Turnitin.pdf https://repository.unair.ac.id/125540/ https://www.sciencedirect.com/science/article/pii/S0019483221002303?via%3Dihub https://doi.org/10.1016/j.ihj.2021.10.011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English English English English |
Similar Items
-
Inotropes in Chronic Beta-Blocker Therapy
by: Mochamad Yusuf Alsagaff, -, et al.
Published: (2021) -
Resistance or pitfall in heparin monitoring: An ongoing issue in COVID-19 anticoagulation
by: Mochamad Yusuf Alsagaff, -, et al.
Published: (2022) -
Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis
by: Mochamad Yusuf Alsagaff, -, et al.
Published: (2021) -
Inotropes in Chronic Beta-Blocker Therapy
by: Mochamad Yusuf Alsagaff, -, et al.
Published: (2021) -
The current status of Beta-blockers in the treatment of hypertension (II)
by: Lock, C.B.
Published: (2016)